Held by the filer's joint per the disclosure. Disclosed 39 days after the transaction; reported as an official range, not an exact amount.
Traded Aug 10, 2026 · Filed Aug 11, 2026
The boss of Aptiv spent $2.5M of their very own money to buy Aptiv shares. 3 other people at Aptiv bought some too, in the same month. Their pile of Aptiv shares grew by 9%.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
open market purchase
Code P — open-market or private purchase
~$2,502,684
Shares × reported transaction price
$1M+
+8.5%
Purchase shares ÷ estimated pre-transaction holdings, from the filing
Not enough history to judge
Confirmed open-market purchases by the same insider in the available history
4 distinct insiders in 30 days
Distinct insiders at the same issuer with confirmed open-market purchases
This purchase equals about 13% of the CEO's reported total pay for fiscal 2025 ($19.3M)
Purchase value ÷ the CEO's total from the Summary Compensation Table, as tagged in the pay versus performance table of the company's proxy statement (DEF 14A), filed 2026-03-16. The proxy names Kevin P. Clark as CEO for that year. A size comparison, not a judgement
6 days after results of Aug 4, 2026
Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results
Closed at $49.81 on Aug 10, 2026, 8% above its 52-week low and 44% below its high, after a 17% drop over the previous 30 trading days
52-week range $46.30 (Aug 6, 2026) to $88.67 (Jan 9, 2026), 8% of the way up, from 251 adjusted closes. 30 trading days earlier: $60.32 on Jun 26, 2026. Describes the past only, not a forecast
None found in footnotes
Only flagged when a footnote says so; never inferred
| After | Stock | S&P 500 | Difference |
|---|---|---|---|
| 7 days | +0.9% | -0.4% | +1.4% |
| 30 days | -6.1% | -1.1% | -5.0% |
Past results only. Not a forecast.
Held by the filer's joint per the disclosure. Disclosed 39 days after the transaction; reported as an official range, not an exact amount.
Held by the filer's joint per the disclosure. Disclosed 39 days after the transaction; reported as an official range, not an exact amount.
A board member of Aptiv spent $199K of their very own money to buy Aptiv shares. 3 other people at Aptiv bought some too, in the same month. Their pile of Aptiv shares grew by 30%.